343 related articles for article (PubMed ID: 32047132)
1. Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.
Marcink TC; Yariv E; Rybkina K; Más V; Bovier FT; des Georges A; Greninger AL; Alabi CA; Porotto M; Ben-Tal N; Moscona A
mBio; 2020 Feb; 11(1):. PubMed ID: 32047132
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
3. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement.
Gui L; Jurgens EM; Ebner JL; Porotto M; Moscona A; Lee KK
mBio; 2015 Feb; 6(1):e02393-14. PubMed ID: 25691596
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
Palmer SG; Porotto M; Palermo LM; Cunha LF; Greengard O; Moscona A
mBio; 2012; 3(3):. PubMed ID: 22669629
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
[TBL] [Abstract][Full Text] [Related]
6. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.
Porotto M; Devito I; Palmer SG; Jurgens EM; Yee JL; Yokoyama CC; Pessi A; Moscona A
J Virol; 2011 Dec; 85(24):12867-80. PubMed ID: 21976650
[TBL] [Abstract][Full Text] [Related]
7. Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces.
Marcink TC; Wang T; des Georges A; Porotto M; Moscona A
PLoS Pathog; 2020 Sep; 16(9):e1008883. PubMed ID: 32956394
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry.
Porotto M; Palmer SG; Palermo LM; Moscona A
J Biol Chem; 2012 Jan; 287(1):778-793. PubMed ID: 22110138
[TBL] [Abstract][Full Text] [Related]
9. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.
Porotto M; Murrell M; Greengard O; Moscona A
J Virol; 2003 Mar; 77(6):3647-54. PubMed ID: 12610140
[TBL] [Abstract][Full Text] [Related]
10. Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells.
Bose S; Song AS; Jardetzky TS; Lamb RA
J Virol; 2014 Apr; 88(8):3925-41. PubMed ID: 24453369
[TBL] [Abstract][Full Text] [Related]
11. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
12. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
[TBL] [Abstract][Full Text] [Related]
13. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.
Porotto M; Salah Z; DeVito I; Talekar A; Palmer SG; Xu R; Wilson IA; Moscona A
J Virol; 2012 May; 86(10):5730-41. PubMed ID: 22438532
[TBL] [Abstract][Full Text] [Related]
14. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering.
Connolly SA; Leser GP; Jardetzky TS; Lamb RA
J Virol; 2009 Nov; 83(21):10857-68. PubMed ID: 19710150
[TBL] [Abstract][Full Text] [Related]
15. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
16. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.
Palmer SG; DeVito I; Jenkins SG; Niewiesk S; Porotto M; Moscona A
J Virol; 2014 Nov; 88(22):13495-502. PubMed ID: 25210187
[TBL] [Abstract][Full Text] [Related]
17. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
Palermo LM; Porotto M; Greengard O; Moscona A
J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of amino acids at stalk/head interface of human parainfluenza virus type 3 hemagglutinin-neuraminidase protein in the membrane fusion process.
Jiang J; Wen H; Chi M; Liu Y; Liu J; Cao Z; Zhao L; Song Y; Liu N; Chi L; Wang Z
Virus Genes; 2018 Jun; 54(3):333-342. PubMed ID: 29516315
[TBL] [Abstract][Full Text] [Related]
19. Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state.
Porotto M; Salah ZW; Gui L; DeVito I; Jurgens EM; Lu H; Yokoyama CC; Palermo LM; Lee KK; Moscona A
J Virol; 2012 Dec; 86(23):12838-48. PubMed ID: 22993149
[TBL] [Abstract][Full Text] [Related]
20. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
